Highlights
NASDAQ: BGNE       Beigene Ltd Ads
Last Price Today's Change   Day's Range   Trading Volume
308.27   -4.73 (1.51%)  302.97 - 327.535  158,000

Overview

 
Avg Volume (4 weeks):253,100
4 Weeks Range:302.97 - 361.00
4 Weeks Price Volatility (%):
9.13%
52 Weeks Range:136.48 - 388.97
52 Weeks Price Volatility (%):
68.04%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

BeiGene Ltd is a United States based clinical-stage biopharmaceutical company. It is engaged in the discovery and development of molecularly targeted and immuno-oncology drugs for the treatment of cancer. The company has developed a proprietary cancer biology platform that addresses the importance of tumor-immune system interactions and the value of primary biopsies in developing new models to support its drug discovery effort. It has developed clinical-stage drug candidates that inhibit the important oncology targets Bruton's tyrosine kinase, or BTK; RAF dimer protein complex and PARP family of proteins, and an immuno-oncology agent that inhibits the immune checkpoint protein receptor PD-1.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

5321  4267  669  146 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 NAKD 0.637-0.083 
 CTRM 0.508-0.025 
 SNDL 1.000.00 
 AAPL 132.99+3.19 
 FUBO 23.31+1.15 
 AFMD 9.74-0.53 
 SQQQ 11.07-0.35 
 NIO 38.12-0.23 
 TENX 2.08-0.01 
 GE 13.60+0.10